Analysis of the Respiratory Disease Testing Market in Europe: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

June 2013 | 335 pages | ID: A96FF343BBBEN
Venture Planning Group

Abstracts

This new 335-page report from Venture Planning Group provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

About this Report

This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales forecasts by country and market segment, including:

• Hospitals
• Commercial/Private Labs
• Physician Offices
• Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country. Also, the report:

• Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; thirteen Reviews features and operating characteristics of major analyzers used for respiratory disease testing; Profiles key suppliers and potential market entrants developing innovative technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the five major European countries.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.

Contains 335 pages and 76 tables

Contents

INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Infectious Disease Tests
  1. Adenovirus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    d. Adeno-Associated Viruses(AAV)
  2. Influenza Viruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
3. Legionella
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
4. Mononucleosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
5. Mycoplasma
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
6. Pneumonia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
7. Respiratory Syncytial Virus (RSV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
8. Tuberculosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs

B. INSTRUMENTATION REVIEW OF LEADING ANALYZERS MARKETED BY ABBOTT, BECKMAN COULTER/DANAHER, BIOMERIEUX, ORTHO-CLINICAL DIAGNOSTICS, ROCHE, SIEMENS, TOSOH, WALLAC AND OTHER SUPPLIERS

C. EMERGING DIAGNOSTIC TECHNOLOGIES

1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other

FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES